The FDA is holding an advisory committee meeting October 22, 2020 to discuss the approval process for COVID-19 vaccines. Though public comments were permitted (and needed to be submitted by October 15, 2020), the FDA did virtually no public outreach to solicit input from stakeholders who have valid input to offer on issues affecting the vaccine trials and approval process. When Dr. David learned of the meeting, and the call for public comments, he decided to submit formal comments on what he believes the FDA could do to improve public confidence in the forthcoming COVID-19 vaccines. In this video, Dr. David discusses the content of the letter he submitted to the FDA’s advisory committee.
You can view the FDA online web conference meeting at:
– or –